129 related articles for article (PubMed ID: 11833715)
1. Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues.
Urayama A; Yamada S; Hirano K; Deguchi Y; Kimura R
Life Sci; 2001 Dec; 70(6):647-57. PubMed ID: 11833715
[TBL] [Abstract][Full Text] [Related]
2. Brain receptor binding characteristics and pharmacokinetics of JTP-2942, a novel thyrotropin-releasing hormone (TRH) analogue.
Urayama A; Yamada S; Deguchi Y; Kimura R; Maeda Y; Kobayashi T
Life Sci; 1999; 65(22):2407-15. PubMed ID: 10597895
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice.
Urayama A; Yamada S; Kimura R; Zhang J; Watanabe Y
Life Sci; 2002 Dec; 72(4-5):601-7. PubMed ID: 12467901
[TBL] [Abstract][Full Text] [Related]
4. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats.
Asai H; Kinoshita K; Yamamura M; Matsuoka Y
Jpn J Pharmacol; 1999 Mar; 79(3):313-7. PubMed ID: 10230859
[TBL] [Abstract][Full Text] [Related]
5. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
[TBL] [Abstract][Full Text] [Related]
6. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
Yamamura M; Suzuki M; Matsumoto K
Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():33P-38P. PubMed ID: 9503402
[TBL] [Abstract][Full Text] [Related]
8. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
[TBL] [Abstract][Full Text] [Related]
9. Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.
Boghosian JD; Luethy A; Cotten JF
J Pharmacol Exp Ther; 2018 Jul; 366(1):105-112. PubMed ID: 29674333
[TBL] [Abstract][Full Text] [Related]
10. Studies on the transport of thyrotropin-releasing hormone (TRH) analogues in Caco-2 cell monolayers.
Urayama A; Yamada S; Deguchi Y; Ohmori Y; Kimura R
J Pharm Pharmacol; 2003 May; 55(5):603-8. PubMed ID: 12831502
[TBL] [Abstract][Full Text] [Related]
11. In vitro biochemical characterization and autoradiographic distribution of 3H-thyrotropin-releasing hormone binding sites in rat brain sections.
Rostène WH; Morgat JL; Dussaillant M; Rainbow TC; Sarrieau A; Vial M; Rosselin G
Neuroendocrinology; 1984 Jul; 39(1):81-6. PubMed ID: 6087185
[TBL] [Abstract][Full Text] [Related]
12. Central and peripheral type benzodiazepine ligands displace [3H][3-ME-HIS2]TRH from its binding sites in the brain and the anterior pituitary and antagonize the effect of TRH in the rat duodenum.
Järvinen A; Paakkari I; Männistö PT
Neuropeptides; 1991 Jul; 19(3):147-55. PubMed ID: 1654530
[TBL] [Abstract][Full Text] [Related]
13. Norvaline2-TRH: binding to TRH receptors in rat brain homogenates.
Vonhof S; Feuerstein GZ; Cohen LA; Labroo VM
Eur J Pharmacol; 1990 May; 180(1):1-12. PubMed ID: 2163861
[TBL] [Abstract][Full Text] [Related]
14. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
Bhargava HN; Das S
Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
[TBL] [Abstract][Full Text] [Related]
15. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
Tanabe M; Tokuda Y; Takasu K; Ono K; Honda M; Ono H
Br J Pharmacol; 2007 Feb; 150(4):403-14. PubMed ID: 17220907
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain permeability of [3H]-(3-methyl-His2)thyrotropin-releasing hormone (MeTRH) in mice: effects of TRH and its analogues.
Urayama A; Yamada S; Ohmori Y; Deguchi Y; Uchida S; Kimura R
Drug Metab Pharmacokinet; 2003; 18(5):310-8. PubMed ID: 15618750
[TBL] [Abstract][Full Text] [Related]
17. First-in-class thyrotropin-releasing hormone (TRH)-based compound binds to a pharmacologically distinct TRH receptor subtype in human brain and is effective in neurodegenerative models.
Kelly JA; Boyle NT; Cole N; Slator GR; Colivicchi MA; Stefanini C; Gobbo OL; Scalabrino GA; Ryan SM; Elamin M; Walsh C; Vajda A; Goggin MM; Campbell M; Mash DC; O'Mara SM; Brayden DJ; Callanan JJ; Tipton KF; Della Corte L; Hunter J; O'Boyle KM; Williams CH; Hardiman O
Neuropharmacology; 2015 Feb; 89():193-203. PubMed ID: 25281210
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologically distinct binding sites in rat brain for [3H]thyrotropin-releasing hormone (TRH) and [3H][3-methyl-histidine(2)]TRH.
Kelly JA; Slator GR; O'Boyle KM
Biochem Pharmacol; 2002 Jun; 63(12):2197-206. PubMed ID: 12110379
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
20. Novel thyrotropin-releasing hormone analogs: a patent review.
Khomane KS; Meena CL; Jain R; Bansal AK
Expert Opin Ther Pat; 2011 Nov; 21(11):1673-91. PubMed ID: 22017410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
